New research suggests that stable heart patients with stents are no better off than patients given less costly drug regimens.
Updated: March 15, 2012 9:30 a.m.
MASSDEVICE ON CALL — Stable heart disease patients were no better off with a stent with less-costly drug therapy in a recent study comparing the 2 treatments. *
Implanting a stent to prop open blocked arteries represents a more costly alternative that failed to improve outcomes in stable patients, according to researchers from the Stony Brook University Medical Center in New York.
"There was no benefit of stenting as far as reducing death, heart attack, repeat procedures and even reducing symptomatic angina," investigator Dr. David Brown told Today Online.
House Dems. call for more oversight of medical devices
House Democrats introduced a bill this month granting the FDA the power to reject devices with designs that predicate from products that were recalled, Bloomberg reported.
Supreme Court keeps Kagan amid calls for recusal
The Supreme Court again denied calls for recusal of Justice Elena Kagan in the legal challenge against President Barack Obama's health care laws, Law360.com (paid) reported.
FDA grants Jarvik Heart trials of destination therapy
NeuWave Medical raised more than $25 million in equity financing as it works to advance the market...
ConforMIS files for an initial public offering worth up to $173 million for its customized joint...
Here's a look at some of the top legal news stories for medical device companies this week: PAD:...
Mind-controlled prosthetics allow quadriplegic Erik Sorto to drink his 1st beer in a decade by...